265 related articles for article (PubMed ID: 19118017)
1. Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.
Cataisson C; Ohman R; Patel G; Pearson A; Tsien M; Jay S; Wright L; Hennings H; Yuspa SH
Cancer Res; 2009 Jan; 69(1):319-28. PubMed ID: 19118017
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion.
Wang HQ; Smart RC
J Cell Sci; 1999 Oct; 112 ( Pt 20)():3497-506. PubMed ID: 10504298
[TBL] [Abstract][Full Text] [Related]
3. Early epidermal destruction with subsequent epidermal hyperplasia is a unique feature of the papilloma-independent squamous cell carcinoma phenotype in PKCepsilon overexpressing transgenic mice.
Li Y; Wheeler DL; Alters W; Chaiswing L; Verma AK; Oberley TD
Toxicol Pathol; 2005; 33(6):684-94. PubMed ID: 16243773
[TBL] [Abstract][Full Text] [Related]
4. CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation.
Cataisson C; Pearson AJ; Tsien MZ; Mascia F; Gao JL; Pastore S; Yuspa SH
J Clin Invest; 2006 Oct; 116(10):2757-66. PubMed ID: 16964312
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of protein kinase Calpha in mice results in impairment of epidermal hyperplasia and enhancement of tumor formation in two-stage skin carcinogenesis.
Hara T; Saito Y; Hirai T; Nakamura K; Nakao K; Katsuki M; Chida K
Cancer Res; 2005 Aug; 65(16):7356-62. PubMed ID: 16103087
[TBL] [Abstract][Full Text] [Related]
6. Activation of cutaneous protein kinase C alpha induces keratinocyte apoptosis and intraepidermal inflammation by independent signaling pathways.
Cataisson C; Joseloff E; Murillas R; Wang A; Atwell C; Torgerson S; Gerdes M; Subleski J; Gao JL; Murphy PM; Wiltrout RH; Vinson C; Yuspa SH
J Immunol; 2003 Sep; 171(5):2703-13. PubMed ID: 12928424
[TBL] [Abstract][Full Text] [Related]
7. Keratinocyte p38δ loss inhibits Ras-induced tumor formation, while systemic p38δ loss enhances skin inflammation in the early phase of chemical carcinogenesis in mouse skin.
Kiss A; Koppel AC; Anders J; Cataisson C; Yuspa SH; Blumenberg M; Efimova T
Mol Carcinog; 2016 May; 55(5):563-74. PubMed ID: 25753147
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling.
Zhu S; Yoon K; Sterneck E; Johnson PF; Smart RC
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):207-12. PubMed ID: 11756662
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes.
Indra AK; Castaneda E; Antal MC; Jiang M; Messaddeq N; Meng X; Loehr CV; Gariglio P; Kato S; Wahli W; Desvergne B; Metzger D; Chambon P
J Invest Dermatol; 2007 May; 127(5):1250-60. PubMed ID: 17301838
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.
Wheeler DL; Ness KJ; Oberley TD; Verma AK
Cancer Res; 2003 Oct; 63(19):6547-55. PubMed ID: 14559850
[TBL] [Abstract][Full Text] [Related]
11. RasGRP1 overexpression in the epidermis of transgenic mice contributes to tumor progression during multistage skin carcinogenesis.
Luke CT; Oki-Idouchi CE; Cline JM; Lorenzo PS
Cancer Res; 2007 Nov; 67(21):10190-7. PubMed ID: 17974959
[TBL] [Abstract][Full Text] [Related]
12. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
Sung YM; He G; Fischer SM
Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
14. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
[TBL] [Abstract][Full Text] [Related]
15. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
16. Ras mutation promotes p53 activation and apoptosis of skin keratinocytes.
Zhao Y; Chaiswing L; Bakthavatchalu V; Oberley TD; St Clair DK
Carcinogenesis; 2006 Aug; 27(8):1692-8. PubMed ID: 16613839
[TBL] [Abstract][Full Text] [Related]
17. Impact of mTORC1 inhibition on keratinocyte proliferation during skin tumor promotion in wild-type and BK5.AktWT mice.
Rho O; Kiguchi K; Jiang G; DiGiovanni J
Mol Carcinog; 2014 Nov; 53(11):871-82. PubMed ID: 24114993
[TBL] [Abstract][Full Text] [Related]
18. Integrin α3β1 Is a Key Regulator of Several Protumorigenic Pathways during Skin Carcinogenesis.
Ramovs V; Krotenberg Garcia A; Kreft M; Sonnenberg A
J Invest Dermatol; 2021 Apr; 141(4):732-741.e6. PubMed ID: 32805217
[TBL] [Abstract][Full Text] [Related]
19. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
20. Gene expression and cellular sources of inducible nitric oxide synthase during tumor promotion.
Robertson FM; Long BW; Tober KL; Ross MS; Oberyszyn TM
Carcinogenesis; 1996 Sep; 17(9):2053-9. PubMed ID: 8824534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
